Strong C E, Schoepfer K J, Dossat A M, Saland S K, Wright K N, Kabbaj M
Department of Biomedical Sciences and Program in Neuroscience, Florida State University, Tallahassee, FL, USA.
Department of Biomedical Sciences and Program in Neuroscience, Florida State University, Tallahassee, FL, USA.
Neuropharmacology. 2017 Jul 15;121:195-203. doi: 10.1016/j.neuropharm.2017.05.003. Epub 2017 May 4.
Clinical evidence suggests superior antidepressant response over time with a repeated, intermittent ketamine treatment regimen as compared to a single infusion. However, the club drug ketamine is commonly abused. Therefore, the abuse potential of repeated ketamine injections at low doses needs to be investigated. In this study, we investigated the abuse potential of repeated exposure to either 0, 2.5, or 5 mg/kg ketamine administered once weekly for seven weeks. Locomotor activity and conditioned place preference (CPP) were assayed to evaluate behavioral sensitization to the locomotor activating effects of ketamine and its rewarding properties, respectively. Our results show that while neither males nor females developed CPP, males treated with 5 mg/kg and females treated with either 2.5 or 5 mg/kg ketamine behaviorally sensitized. Furthermore, dendritic spine density was increased in the NAc of both males and females administered 5 mg/kg ketamine, an effect specific to the NAc shell (NAcSh) in males but to both the NAc core (NAcC) and NAcSh in females. Additionally, males administered 5 mg/kg ketamine displayed increased protein expression of ΔfosB, calcium calmodulin kinase II alpha (CaMKIIα), and brain-derived neurotrophic factor (BDNF), an effect not observed in females administered either dose of ketamine. However, males and females administered 5 mg/kg ketamine displayed increased protein expression of AMPA receptors (GluA1). Taken together, low-dose ketamine, when administered intermittently, induces behavioral sensitization at a lower dose in females than males, accompanied by an increase in spine density in the NAc and protein expression changes in pathways commonly implicated in addiction.
临床证据表明,与单次输注相比,重复、间歇性氯胺酮治疗方案随着时间推移具有更好的抗抑郁反应。然而,俱乐部毒品氯胺酮常被滥用。因此,需要研究低剂量重复注射氯胺酮的滥用潜力。在本研究中,我们调查了每周一次、连续七周重复暴露于0、2.5或5mg/kg氯胺酮的滥用潜力。分别测定运动活性和条件性位置偏爱(CPP),以评估对氯胺酮运动激活作用及其奖赏特性的行为敏化。我们的结果表明,虽然雄性和雌性均未形成CPP,但接受5mg/kg氯胺酮治疗的雄性和接受2.5或5mg/kg氯胺酮治疗的雌性出现了行为敏化。此外,接受5mg/kg氯胺酮治疗的雄性和雌性的伏隔核(NAc)树突棘密度均增加,这种效应在雄性中特异性地发生在伏隔核壳(NAcSh),而在雌性中则发生在伏隔核核心(NAcC)和NAcSh两者。此外,接受5mg/kg氯胺酮治疗的雄性显示ΔfosB、钙调蛋白激酶IIα(CaMKIIα)和脑源性神经营养因子(BDNF)的蛋白表达增加,而在接受任何剂量氯胺酮治疗的雌性中未观察到这种效应。然而,接受5mg/kg氯胺酮治疗的雄性和雌性均显示α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体(GluA1)的蛋白表达增加。综上所述,低剂量氯胺酮间歇性给药时,雌性比雄性在更低剂量下诱导行为敏化,同时伴有NAc中棘密度增加以及成瘾相关通路中蛋白表达变化。